Netherlands· NL-28bfadf41d9c
Catapresan, oplossing voor injectie 0,150 mg/ml
A clonidine product containing clonidinehydrochloride, registered in Netherlands by Glenwood GmbH Pharmazeutische Erzeugnisse. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Clonidine is registered in 13 of 19 countries.
Countries holding a registration under ATC C02AC01 (clonidine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Clonidine · ATC C02AC01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of clonidine costs, country by country.
Normalised to the WHO defined daily dose (0.45 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Clonidine · price per daily dose (0.45 mg)
USD · FX 28 Sept 2026
- US United States$0.074 (acquisition cost)
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CLONIDINEHYDROCHLORIDE
- Manufacturer
- Glenwood GmbH Pharmazeutische Erzeugnisse
- Country
- Netherlands (NL)
- ATC code
- C02AC01
- ATC class
- Clonidine
- Defined daily dose
- 0.45 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id06055
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
307 interactions on record for clonidine.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clonidine · interactions on record
307 records
- 2 severe
- 127 moderate
- 2 minor
- 175 info
Most severe, free to view
- DoxepinD04AX01severe
- DoxepinN06AA12severe
- MetoclopramideA03FA01moderate
- ThiethylperazinA04AB03moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clonidine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenCaruxin 150 mikrogram/ml Injektionsvätska, lösningMACURE PHARMA ApS
- NorwayCaruxinMacure Pharma ApS
- CzechiaCLONIDINA CLORIDRATO BIOINDUSTRIA L.I.M.
- United StatesCatapres-TTS-1Technomed Inc.
- United KingdomCatapres 100microgram tabletsGlenwood GmbH
- GermanyAlcaridinCarinopharm Gmbh
- CanadaCLONIDINESIVEM PHARMACEUTICALS ULC
- FinlandCaprysinSchering Oy
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Catapresan
- Belgium · Catapressan
- Bulgaria · Хлофазолин
- Czechia · Clonidine Olikla
- Germany · Alcaridin, Catapresan
- Denmark · Caruxin, Clopressan
- Spain · Catapresan
- Finland · Catapresan, Clonidine Macure
- France · Catapressan
- United Kingdom (Northern Ireland) · Calotep, Catapres
- Greece · Catapresan
- Ireland · Catapres, Catapres Ampoules
- Italy · Catapresan, Catapresan Tts-1
- Luxembourg · Catapressan
- Latvia · Chlophazolin
- Malta · Alcaridin, Catapres Tablets
- Norway · Caruxin, Clotaxip
- Poland · Iporel
- Portugal · Catapresan, Edolglau
- Romania · Clonidină Arena, Clonidina Sintofarm
- Sweden · Caruxin, Catapresan
- Slovakia · Clonidine Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8218d38d-f4e4-40f2-86f7-5ce34aa7c135 GET /v1/drugs/8218d38d-f4e4-40f2-86f7-5ce34aa7c135?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oplossing voor injectie",
"route": null,
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h06055_smpc.pdf",
"strength": null,
"atc_label": "Clonidine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg06055",
"excipients": [
"NATRIUMCHLORIDE",
"WATER VOOR INJECTIE",
"ZOUTZUUR (E 507)"
],
"substances": [
"CLONIDINEHYDROCHLORIDE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h06055.pdf",
"authorised_at": "1971/04/28",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "06055",
"additional_monitoring": "N"
}See everything about clonidine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.